Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial.
Neil
H A W
HA
NIHR School of Primary Care Research, Division of Public Health & Primary Health Care, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK. andrew.neil@wolfson.ox.ac.uk
Ceglarek
U
U
Thiery
J
J
Paul
S
S
Farmer
A
A
Holman
R R
RR
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000069059:Atorvastatin; D002784:Cholesterol / Q000031:analogs & derivatives / Q000096:biosynthesis* / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000378:metabolism*; D004281:Docosahexaenoic Acids / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use*; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D007810:Lanosterol / Q000097:blood; D010840:Phytosterols / Q000097:blood; D011758:Pyrroles / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D004338:Drug Combinations; D006538:Heptanoic Acids; D010840:Phytosterols; D011758:Pyrroles; D014280:Triglycerides; D007810:Lanosterol; D004281:Docosahexaenoic Acids; C021273:campesterol; D002784:Cholesterol; D000069059:Atorvastatin; D015118:Eicosapentaenoic Acid; C405603:Omacor